Date
2018
Abstract
Herpes zoster (shingles) is a viral infection that results in a painful rash and has a myriad of long-term complications, including post-herpetic neuralgia- chronic pain that does not resolved despite resolution of the rash. Over the last 20 years, incidence of shingles has increased by nearly 50% and now there are 2 vaccines available to prevent shingles. Shingrix was approved by the FDA in 2017 and has garnered public attention for its efficacy. I developed a brochure that gives patients information about shingles, Shingrix, and answers some frequently asked questions.
Clinical Site
Brookfield Family Practice- Brookfield, CT
Keywords
shingles, shingrix, vaccine, elderly, varicella, zoster, rash
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Disciplines
Medical Education | Primary Care
Recommended Citation
Jost, Sarah Natasha, "Shingrix: Educating Patients on the New Shingles Vaccine" (2018). Family Medicine Clerkship Student Projects. 360.
https://scholarworks.uvm.edu/fmclerk/360